Preeyaporn Srasuebkul

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. pmc Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research NCHECR, University of New South Wales, Sydney, NSW, Australia
    AIDS Res Ther 4:18. 2007
  2. ncbi request reprint Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment
    P Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Sydney, NSW 2010, Australia
    HIV Med 8:46-54. 2007
  3. pmc Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
    Clin Infect Dis 48:940-50. 2009
  4. doi request reprint Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
    Rebekah L Puls
    National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, 45 Beach St, Coogee, New South Wales, Australia, 2034
    Clin Infect Dis 51:855-64. 2010
  5. ncbi request reprint The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
    P Cardiello
    The HIV Netherlands Australia Thailand Research Collaborative HIVNAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
    HIV Med 6:122-8. 2005
  6. ncbi request reprint Prior antiretroviral therapy experience protects against zidovudine-related anaemia
    S E Huffam
    National Center for HIV AIDS, Dermatology and STDs NCHADS, Ministry of Health, Phnom Penh, Cambodia
    HIV Med 8:465-71. 2007

Collaborators

Detail Information

Publications6

  1. pmc Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research NCHECR, University of New South Wales, Sydney, NSW, Australia
    AIDS Res Ther 4:18. 2007
    ..We aimed at exploring rates and predictors of ART combination changes in clinical practice in Treat Asia HIV Observational Database (TAHOD)...
  2. ncbi request reprint Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment
    P Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Sydney, NSW 2010, Australia
    HIV Med 8:46-54. 2007
    ..Routine CD4 count and HIV viral load monitoring is a financial barrier in developing countries...
  3. pmc Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
    Clin Infect Dis 48:940-50. 2009
    ....
  4. doi request reprint Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
    Rebekah L Puls
    National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, 45 Beach St, Coogee, New South Wales, Australia, 2034
    Clin Infect Dis 51:855-64. 2010
    ..Antiretroviral therapy is complicated by drug interactions and contraindications. Novel regimens are needed...
  5. ncbi request reprint The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
    P Cardiello
    The HIV Netherlands Australia Thailand Research Collaborative HIVNAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
    HIV Med 6:122-8. 2005
    ....
  6. ncbi request reprint Prior antiretroviral therapy experience protects against zidovudine-related anaemia
    S E Huffam
    National Center for HIV AIDS, Dermatology and STDs NCHADS, Ministry of Health, Phnom Penh, Cambodia
    HIV Med 8:465-71. 2007
    ....